Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toni I Pollin

Showing results (131-140 of 148) with videos related to

Pageof 15
Sort By:
Diabetes Care|June 28, 2022
Model for Integration of Monogenic Diabetes Diagnosis Into Routine Care: The Personalized Diabetes Medicine ProgramHaichen Zhang, Jeffrey W Kleinberger, Kristin A Maloney, et al.
BMC Medical Genomics|May 24, 2017
Challenges and strategies for implementing genomic services in diverse settings: experiences from the Implementing GeNomics In pracTicE (IGNITE) networkNina R Sperber, Janet S Carpenter, Larisa H Cavallari, et al.
Nature Genetics|October 22, 2024
Publisher Correction: Rare variant analyses in 51,256 type 2 diabetes cases and 370,487 controls reveal the pathogenicity spectrum of monogenic diabetes genesAlicia Huerta-Chagoya, Philip Schroeder, Ravi Mandla, et al.
Nature Genetics|October 8, 2024
Rare variant analyses in 51,256 type 2 diabetes cases and 370,487 controls reveal the pathogenicity spectrum of monogenic diabetes genesAlicia Huerta-Chagoya, Philip Schroeder, Ravi Mandla, et al.
Nature Genetics|March 26, 2025
Author Correction: Rare variant analyses in 51,256 type 2 diabetes cases and 370,487 controls reveal the pathogenicity spectrum of monogenic diabetes genesAlicia Huerta-Chagoya, Philip Schroeder, Ravi Mandla, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 6, 2023
Recommendations for risk allele evidence curation, classification, and reporting from the ClinGen Low Penetrance/Risk Allele Working GroupRyan J Schmidt, Marcie Steeves, Pinar Bayrak-Toydemir, et al.
American Heart Journal|April 29, 2008
The genetic response to short-term interventions affecting cardiovascular function: rationale and design of the Heredity and Phenotype Intervention (HAPI) Heart StudyBraxton D Mitchell, Patrick F McArdle, Haiqing Shen, et al.
Diabetes|August 29, 2006
Variation within the gene encoding the upstream stimulatory factor 1 does not influence susceptibility to type 2 diabetes in samples from populations with replicated evidence of linkage to chromosome 1qEleftheria Zeggini, Coleen M Damcott, Robert L Hanson, et al.
BMC Medical Genomics|January 6, 2016
The IGNITE network: a model for genomic medicine implementation and researchKristin Wiisanen Weitzel, Madeline Alexander, Barbara A Bernhardt, et al.
JACC. Cardiovascular Interventions|November 6, 2017
Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary InterventionLarisa H Cavallari, Craig R Lee, Amber L Beitelshees, et al.
Pageof 15

Showing results (131-140 of 148) with videos related to

Sort By:
Pageof 15
Diabetes Care|June 28, 2022
Model for Integration of Monogenic Diabetes Diagnosis Into Routine Care: The Personalized Diabetes Medicine ProgramHaichen Zhang, Jeffrey W Kleinberger, Kristin A Maloney, et al.
BMC Medical Genomics|May 24, 2017
Challenges and strategies for implementing genomic services in diverse settings: experiences from the Implementing GeNomics In pracTicE (IGNITE) networkNina R Sperber, Janet S Carpenter, Larisa H Cavallari, et al.
Nature Genetics|October 22, 2024
Publisher Correction: Rare variant analyses in 51,256 type 2 diabetes cases and 370,487 controls reveal the pathogenicity spectrum of monogenic diabetes genesAlicia Huerta-Chagoya, Philip Schroeder, Ravi Mandla, et al.
Nature Genetics|October 8, 2024
Rare variant analyses in 51,256 type 2 diabetes cases and 370,487 controls reveal the pathogenicity spectrum of monogenic diabetes genesAlicia Huerta-Chagoya, Philip Schroeder, Ravi Mandla, et al.
Nature Genetics|March 26, 2025
Author Correction: Rare variant analyses in 51,256 type 2 diabetes cases and 370,487 controls reveal the pathogenicity spectrum of monogenic diabetes genesAlicia Huerta-Chagoya, Philip Schroeder, Ravi Mandla, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 6, 2023
Recommendations for risk allele evidence curation, classification, and reporting from the ClinGen Low Penetrance/Risk Allele Working GroupRyan J Schmidt, Marcie Steeves, Pinar Bayrak-Toydemir, et al.
American Heart Journal|April 29, 2008
The genetic response to short-term interventions affecting cardiovascular function: rationale and design of the Heredity and Phenotype Intervention (HAPI) Heart StudyBraxton D Mitchell, Patrick F McArdle, Haiqing Shen, et al.
Diabetes|August 29, 2006
Variation within the gene encoding the upstream stimulatory factor 1 does not influence susceptibility to type 2 diabetes in samples from populations with replicated evidence of linkage to chromosome 1qEleftheria Zeggini, Coleen M Damcott, Robert L Hanson, et al.
BMC Medical Genomics|January 6, 2016
The IGNITE network: a model for genomic medicine implementation and researchKristin Wiisanen Weitzel, Madeline Alexander, Barbara A Bernhardt, et al.
JACC. Cardiovascular Interventions|November 6, 2017
Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary InterventionLarisa H Cavallari, Craig R Lee, Amber L Beitelshees, et al.
Pageof 15